शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
EMCUREBSEEMCURE PHARMACEUTICALS L· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 6 Aug, 2026 · 15:10 IST

Emcure Pharma fixes record date for final dividend, 45th AGM on Sept 21, 2026

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹1950.00
prior close
₹1941.40
announcement price
In-mkt
timing
Nifty Smallcap 250market+0.2%-0.9% vs market
Pharmaceuticals peers, median of 167sector-0.2%-0.6% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Smallcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.6
15m
-0.7
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7+0.2-0.9-0.2-0.6
Next day
+1.6+0.2+1.5+0.3+1.3
2d
+2.4+0.1+2.3+0.6+1.8
3d
+2.5+0.3+2.2+0.6+1.9
4d
+2.8+0.1+2.8+0.5+2.3
5d
+2.9+0.2+2.7+0.9+2.1
1w
-3.7-0.1-3.6-0.1-3.6
15d
-3.7+0.6-4.3+0.0-3.7
1m
-1.5+0.9-2.4+2.5-4.0
2m
-1.5-2.3+0.8+2.6-4.1
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Emcure Pharmaceuticals has fixed September 04, 2026 as the record date to determine shareholders eligible for the final dividend of Rs 3.60 per equity share (36 percent) for FY ending March 31, 2026. The 45th AGM will be held on September 21, 2026 via video conferencing. Dividend, subject to TDS, will be paid within 30 days of AGM approval.

Likely market impact

Investors holding shares by Sept 04 record date will receive the final dividend of Rs 3.60 per share, pending AGM approval.